Benton Visual Retention Test
Benton Visual Retention Test (BVRT) is a widely used neuropsychological test designed to measure visual perception and visual memory. It was developed by Arthur Benton, a neuropsychologist, in the mid-20th century. The test is used to identify and diagnose a variety of neurological and psychological conditions.
Overview[edit]
The Benton Visual Retention Test involves the presentation of a series of ten designs, one at a time, which the individual is then asked to reproduce from memory. The designs vary in complexity and are presented in a specific order. The test is designed to measure an individual's ability to retain visual information and reproduce it accurately.
Uses[edit]
The BVRT is used in a variety of clinical and research settings. It is often used in the assessment of individuals with suspected neurological disorders, including stroke, dementia, and traumatic brain injury. It can also be used to assess visual memory in individuals with psychiatric disorders, such as schizophrenia.
Scoring[edit]
Scoring for the BVRT is based on the accuracy of the reproductions. Errors are categorized into several types, including distortions, rotations, perseverations, and omissions. The total number of errors is used to generate a score, which can then be compared to normative data to determine the individual's level of visual memory.
Limitations[edit]
While the BVRT is a valuable tool in neuropsychological assessment, it does have some limitations. It is not suitable for use with individuals who have severe visual or motor impairments, as these can interfere with the ability to complete the test. Additionally, the test does not provide a comprehensive assessment of visual memory and should be used in conjunction with other measures.
See also[edit]
References[edit]

This article is a psychology-related stub. You can help WikiMD by expanding it!
-
Benton Visual Retention Test
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
